The new outbreak of monkeypox, a viral zoonotic disease, has affected more than 82,500 people and at least 110 countries worldwide as of 14 December 2022, with 81,580 people affected in 103 non-endemic areas of Africa [...].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863898 | PMC |
| http://dx.doi.org/10.3390/vaccines11010010 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mpox and the men who have sex with men (MSM) community in Nigeria: Exploratory insights from MSM and persons providing healthcare services to them.
Glob Public Health
December 2025
Health & Nutrition Cluster, Institute of Development Studies, University of Sussex, Brighton, United Kingdom.
The current mpox outbreak has challenged previous understanding of the disease, with human-to-human transmission being a significant mode of transmission, particularly among gay, bisexual, and other men who have sex with men (GBMSM). A knowledge gap exists on MSM's mpox experiences in Nigeria's restrictive sociolegal context. This study explored mpox awareness, knowledge, and experiences among MSM in Lagos, Nigeria, through 28 in-depth interviews.
View Article and Find Full Text PDFThe current status and future prospects of CRISPR-based detection of monkeypox virus: A review.
Anal Chim Acta
January 2025
Department of Quality Control Material R&D, Shanghai Center for Clinical Laboratory, Shanghai, PR China; Department of Molecular Biology, Shanghai Center for Clinical Laboratory, Shanghai, PR China; Department of Molecular Diagnostic Innovation Technology, Shanghai Academy of Experimental Medicine, Shanghai, PR China. Electronic address:
Background: The current pandemic of 2022 global mpox (formerly known as monkeypox), caused by infection with monkeypox virus (MPXV), has now reached over 120 countries. This constitutes a critical public health issue requiring effective disease management and surveillance. Rapid and reliable diagnosis is conducive to the control of infection, early intervention, and timely treatment.
View Article and Find Full Text PDFChallenges in Global Distribution and Equitable Access to Monkeypox Vaccines.
Viruses
November 2024
Seventh-Day Adventist College of Nursing, Ile-Ife 220103, Nigeria.
The monkeypox outbreak has grown beyond the regions in which it was considered endemic. It has spread from central and west Africa to non-endemic regions like Europe, America, and other parts of the world. It has recently been classified as a public health emergency of international concern.
View Article and Find Full Text PDFA retrospective chart review and thematic analysis of patients seeking mpox vaccination during the initial outbreak in 2022-2023: evaluation of access, motivations, and stigma.
BMC Public Health
December 2024
School of Nursing, Health, York University, Rm. 329A, Health, Nursing and Environmental Studies Building, 104 Scholars Walk, Toronto, M3J 1P3, Canada.
Background: Mpox was identified in many previously non-endemic countries, including Canada, as of May 2022. In response to the increase in cases in Canada, and more specifically the province of Ontario, the vaccine Imvamune was rolled out. Eligibility was governed by provincial health authorities, and the response varied by region.
View Article and Find Full Text PDFZein-based nanostructured coatings: A green approach to enhance virucidal efficacy of protective face masks.
Int J Biol Macromol
December 2024
Institute for Polymers, Composites and Biomaterials (IPCB-CNR), National Research Council, Piazzale E. Fermi 1, 80055 Portici, Naples, Italy.
Face masks represent a valuable tool to prevent the spreading of airborne viruses; however, they show poor comfort and scarce antiviral efficacy. Zein-based coatings are herein exploited to enhance antiviral performance. Zein functionalization is done through acidifying agents (lactic acid, LA).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!